{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:25:28Z","timestamp":1791905128021,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019475","name":"Sidra Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","award":["QUCG-CAS-23\/24-114"],"award-info":[{"award-number":["QUCG-CAS-23\/24-114"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004397","name":"Ministry of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019460","name":"Weill Cornell Medicine - Qatar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.eclinm.2023.102102","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T01:09:00Z","timestamp":1689815340000},"page":"102102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study"],"prefix":"10.1016","volume":"62","author":[{"given":"Suelen H.","family":"Qassim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiam","family":"Chemaitelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2512-6657","authenticated-orcid":false,"given":"Houssein H.","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi M.","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa A.","family":"Al Thani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebah A.","family":"Al-Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaina","family":"Al-Kanaani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einas","family":"Al-Kuwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jeremijenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvar Hassan","family":"Kaleeckal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Nizar","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyazuddin Mohammad","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan F.","family":"Abdul-Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheyath K.","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ghaith","family":"Al-Kuwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel A.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad Eid","family":"Al-Romaihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Al-Thani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif","family":"Al-Khal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bertollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0790-0506","authenticated-orcid":false,"given":"Laith J.","family":"Abu-Raddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eclinm.2023.102102_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc2104974","article-title":"Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants","volume":"385","author":"Abu-Raddad","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102102_bib2","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41591-021-01446-y","article-title":"mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar","volume":"27","author":"Chemaitelly","year":"2021","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.eclinm.2023.102102_bib3","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102102_bib4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMc2119432","article-title":"Waning mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar","volume":"386","author":"Abu-Raddad","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"10328","key":"10.1016\/j.eclinm.2023.102102_bib5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102102_bib6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S1473-3099(22)00409-1","article-title":"Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant","volume":"22","author":"Higdon","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"16","key":"10.1016\/j.eclinm.2023.102102_bib7","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102102_bib8","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1038\/s41467-022-30895-3","article-title":"Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar","volume":"13","author":"Chemaitelly","year":"2022","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.eclinm.2023.102102_bib9","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMoa2200797","article-title":"Effect of mRNA vaccine boosters against SARS-CoV-2 omicron infection in Qatar","volume":"386","author":"Abu-Raddad","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102102_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1473-3099(23)00058-0","article-title":"Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study","volume":"23","author":"Chemaitelly","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102102_bib11","doi-asserted-by":"crossref","first-page":"e1830","DOI":"10.1093\/cid\/ciaa1846","article-title":"Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense reexposure setting","volume":"73","author":"Abu-Raddad","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2023.102102_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100861","article-title":"SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy","volume":"35","author":"Abu-Raddad","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102102_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac109","article-title":"Duration of immune protection of SARS-CoV-2 natural infection against reinfection","volume":"29","author":"Chemaitelly","year":"2022","journal-title":"J\u00a0Travel Med"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102102_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2203965","article-title":"Effects of previous infection and vaccination on symptomatic omicron infections","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.eclinm.2023.102102_bib15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMc2200133","article-title":"Protection against the omicron variant from previous SARS-CoV-2 infection","volume":"386","author":"Altarawneh","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102102_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJMc2214114","article-title":"Protection against reinfection with the omicron BA.2.75 subvariant","volume":"388","author":"Chemaitelly","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102102_bib17","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1038\/s41467-022-32363-4","article-title":"Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage","volume":"13","author":"Chemaitelly","year":"2022","journal-title":"Nat Commun"},{"issue":"17","key":"10.1016\/j.eclinm.2023.102102_bib18","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMc2209306","article-title":"Protective effect of previous SARS-CoV-2 infection against omicron BA.4 and BA.5 subvariants","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102102_bib19","doi-asserted-by":"crossref","first-page":"ofac138","DOI":"10.1093\/ofid\/ofac138","article-title":"A\u00a0systematic review of coronavirus disease 2019 vaccine efficacy and effectiveness against severe acute respiratory syndrome coronavirus 2 infection and disease","volume":"9","author":"Higdon","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102102_bib20","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1038\/s41598-021-85428-7","article-title":"Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic","volume":"11","author":"Abu-Raddad","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102102_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003879","article-title":"Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: a nationally representative cohort study","volume":"18","author":"Abu-Raddad","year":"2021","journal-title":"PLoS Med"},{"issue":"27","key":"10.1016\/j.eclinm.2023.102102_bib22","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1056\/NEJMc2110300","article-title":"Efficacy of natural immunity against SARS-CoV-2 reinfection with the Beta variant","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.102102_bib23","article-title":"Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB\u2217 infections","author":"Chemaitelly","year":"2023","journal-title":"medRxiv"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102102_bib24","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/s41591-021-01583-4","article-title":"BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar","volume":"27","author":"Tang","year":"2021","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102102_bib25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMc2117933","article-title":"Effectiveness of mRNA-1273 and BNT162b2 vaccines in Qatar","volume":"386","author":"Abu-Raddad","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.102102_bib26","article-title":"Short- and longer-term all-cause mortality among SARS-CoV-2- infected persons and the pull-forward phenomenon in Qatar","author":"Chemaitelly","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.eclinm.2023.102102_bib27","article-title":"Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design","author":"Ayoub","year":"2022","journal-title":"medRxiv"},{"issue":"17","key":"10.1016\/j.eclinm.2023.102102_bib28","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.vaccine.2013.02.053","article-title":"The test-negative design for estimating influenza vaccine effectiveness","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.eclinm.2023.102102_bib29","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2017.04.037","article-title":"Case-control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls","volume":"35","author":"Verani","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102102_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant","volume":"385","author":"Lopez Bernal","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.102102_bib31","article-title":"Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19","volume":"11","author":"Ayoub","year":"2021","journal-title":"J\u00a0Glob Health"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102102_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102646","article-title":"SARS-CoV-2 seroprevalence in the urban population of Qatar: an analysis of antibody testing on a sample of 112,941 individuals","volume":"24","author":"Coyle","year":"2021","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102102_bib33","doi-asserted-by":"crossref","first-page":"ofab221","DOI":"10.1093\/ofid\/ofab221","article-title":"SARS-CoV-2 infection is at herd immunity in the majority segment of the population of Qatar","volume":"8","author":"Al-Thani","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102102_bib34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3201\/eid2705.204365","article-title":"Herd immunity against severe acute respiratory syndrome coronavirus 2 infection in 10 communities, Qatar","volume":"27","author":"Jeremijenko","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102102_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab083","article-title":"Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses","volume":"28","author":"Abu-Raddad","year":"2021","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.eclinm.2023.102102_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.112911","article-title":"SARS-CoV-2 reinfections: overview of efficacy and duration of natural and hybrid immunity","author":"Pilz","year":"2022","journal-title":"Environ Res"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102102_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/01632787211047932","article-title":"A\u00a0systematic review of the protective effect of prior SARS-CoV-2 infection on repeat infection","volume":"44","author":"Kojima","year":"2021","journal-title":"Eval Health Prof"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102102_bib40","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational Research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simulat Comput"},{"issue":"25","key":"10.1016\/j.eclinm.2023.102102_bib41","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1016\/j.vaccine.2013.08.048","article-title":"Is it necessary to adjust for calendar time in a test negative design?: responding to: jackson ML, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31(April (17)):2165-8","volume":"32","author":"Jacoby","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2023.102102_bib42","doi-asserted-by":"crossref","first-page":"i969","DOI":"10.1136\/bmj.i969","article-title":"Analysis of matched case-control studies","volume":"352","author":"Pearce","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2023.102102_bib43","series-title":"Modern epidemiology","author":"Rothman","year":"2008"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102102_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41467-023-35815-7","article-title":"Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5","volume":"14","author":"Tseng","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.eclinm.2023.102102_bib45","article-title":"A\u00a0turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar","author":"Chemaitelly","year":"2023","journal-title":"medRxiv"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102102_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012291","article-title":"All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic","volume":"8","author":"AlNuaimi","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102102_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97606-8","article-title":"SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar","volume":"11","author":"Seedat","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102102_bib48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41591-022-01836-w","article-title":"An early warning system for emerging SARS-CoV-2 variants","volume":"28","author":"Subissi","year":"2022","journal-title":"Nat Med"},{"issue":"6493","key":"10.1016\/j.eclinm.2023.102102_bib49","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.abb5793","article-title":"Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period","volume":"368","author":"Kissler","year":"2020","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102102_bib50","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1016\/S2666-5247(21)00180-4","article-title":"Immune-mediated attenuation of influenza illness after infection: opportunities and challenges","volume":"2","author":"Patel","year":"2021","journal-title":"Lancet Microbe"},{"issue":"6530","key":"10.1016\/j.eclinm.2023.102102_bib51","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.abe6522","article-title":"Immunological characteristics govern the transition of COVID-19 to endemicity","volume":"371","author":"Lavine","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.eclinm.2023.102102_bib52","article-title":"COVID-19 primary series and booster vaccination and immune imprinting","author":"Chemaitelly","year":"2022","journal-title":"medRxiv"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102102_bib53","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1086\/656586","article-title":"Seasonal influenza vaccine and increased risk of pandemic A\/H1N1-related illness: first detection of the association in British Columbia, Canada","volume":"51","author":"Janjua","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"46","key":"10.1016\/j.eclinm.2023.102102_bib54","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.46.1900585","article-title":"Paradoxical clade- and age-specific vaccine effectiveness during the 2018\/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)","volume":"24","author":"Skowronski","year":"2019","journal-title":"Euro Surveill"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102102_bib55","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/cid\/ciz706","article-title":"Depletion-of-susceptibles bias in analyses of intra-season waning of influenza vaccine effectiveness","volume":"70","author":"Ray","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023002791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023002791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:20:16Z","timestamp":1762899616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023002791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":53,"alternative-id":["S2589537023002791"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102102","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.28.23289254","asserted-by":"object"}]},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102102"}}